Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-10-15

FDA Approved: METHYLPHENIDATE HYDROCHLORIDE (LA) — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved an original application for methylphenidate hydrochloride (long-acting) generic product by Teva Pharmaceuticals USA, Inc. for the treatment of atte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methylphenidate hydrochloride (LA) (Methylphenidate hydrochloride)

Snippet

ORIG AP for METHYLPHENIDATE HYDROCHLORIDE (LA) (METHYLPHENIDATE HYDROCHLORIDE)